1-(4-methylbenzyl)imidazolidin-2-one | 896682-65-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(4-methylbenzyl)imidazolidin-2-one
• 英文别名: 1-[(4-Methylphenyl)methyl]imidazolidin-2-one
• CAS: 896682-65-8
• 化学式: C₁₁H₁₄N₂O
• 分子量: 190.245
• InChiKey: HHSBGGZSZPZXDQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.52
• 重原子数：
  14.0
• 可旋转键数：
  2.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  32.34
• 氢给体数：
  1.0
• 氢受体数：
  1.0

反应信息

• 作为反应物：
  描述：

  1-(4-methylbenzyl)imidazolidin-2-one 在 sodium hydride 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 异丙醇 为溶剂， 反应 24.5h， 生成 1-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-3-(4-methylbenzyl)imidazolidin-2-one
  参考文献：
  名称：

  [EN] IMIDAZOLIDIN-2-ONE COMPOUNDS AS PRMT5 MODULATORS
  [FR] COMPOSÉS D'IMIDAZOLIDIN-2-ONE EN TANT QUE MODULATEURS DE PRMT5

  摘要：

  本发明涉及公式（I）化合物的衍生物及其药用可接受的盐。本发明还提供了制备公式（I）化合物的方法以及将其用作PRMT5抑制剂的用途。这些化合物在治疗需要PRMT5抑制的情况下非常有用，如癌症、代谢紊乱、炎症、自身免疫疾病和血红蛋白病的治疗。

  公开号：

  WO2019180628A1
• 作为产物：
  描述：

  tert-butyl 2-(4-methylbenzylamino)ethylcarbamate 在 potassium tert-butylate 作用下， 以 四氢呋喃 为溶剂， 反应 3.0h， 以67%的产率得到1-(4-methylbenzyl)imidazolidin-2-one
  参考文献：
  名称：

  Inhibitory effect of novel tetrahydropyrimidine-2(1H)-thiones on melanogenesis

  摘要：

  The series of imidazoldine-2-thiones 2 and tetrahydropyrimidine-2-thiones 3 were discovered as inhibitor of alpha-MSH-induced melanin production in melanoma B16 cells. The primary bioassay showed that 1-(4-ethylbenzyl)-tetrahydropyrimidine-2(1H)-thione 3e (> 100% inhibition at 10 mu M, IC50 = 1.2 mu M) and 1-(4-tert-butylbenzyl)-tetrahydropyrimidine-2(1H)-thione 3f (> 100% inhibition at 10 mu M, IC50 = 0.76 mu M) exhibited potent inhibitory effect against alpha-MSH-induced melanin production. Compounds 3 inhibit the biosynthesis of tyrosinase without affecting its catalytic activity in melanogenesis. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2009.12.044

文献信息

• IMIDAZOLIDIN-2-ONE COMPOUNDS AS PRMT5 MODULATORS
  申请人：Aurigene Discovery Technologies Limited

  公开号：EP3768670A1

  公开（公告）日：2021-01-27
• [EN] IMIDAZOLIDIN-2-ONE COMPOUNDS AS PRMT5 MODULATORS<br/>[FR] COMPOSÉS D'IMIDAZOLIDIN-2-ONE EN TANT QUE MODULATEURS DE PRMT5
  申请人：AURIGENE DISCOVERY TECH LTD

  公开号：WO2019180628A1

  公开（公告）日：2019-09-26

  The present invention relates to the derivatives of compound of formula (I) and pharmaceutically acceptable salts thereof. The present invention further provides the methods of preparation of compound of formula (I) and use thereof as PRMT5 inhibitors. The compounds are useful as medicaments in the treatment of conditions where PRMT5 inhibition is desired, such as cancer, metabolic disorders, inflammation, autoimmune disease and hemoglobinopathies.

  本发明涉及公式（I）化合物的衍生物及其药用可接受的盐。本发明还提供了制备公式（I）化合物的方法以及将其用作PRMT5抑制剂的用途。这些化合物在治疗需要PRMT5抑制的情况下非常有用，如癌症、代谢紊乱、炎症、自身免疫疾病和血红蛋白病的治疗。
• Inhibitory effect of novel tetrahydropyrimidine-2(1H)-thiones on melanogenesis
  作者：P. Thanigaimalai、Ki-Cheul Lee、Seong-Cheol Bang、Jee-Hyun Lee、Cheong-Yong Yun、Eunmiri Roh、Bang-Yeon Hwang、Youngsoo Kim、Sang-Hun Jung

  DOI：10.1016/j.bmc.2009.12.044

  日期：2010.2

  The series of imidazoldine-2-thiones 2 and tetrahydropyrimidine-2-thiones 3 were discovered as inhibitor of alpha-MSH-induced melanin production in melanoma B16 cells. The primary bioassay showed that 1-(4-ethylbenzyl)-tetrahydropyrimidine-2(1H)-thione 3e (> 100% inhibition at 10 mu M, IC50 = 1.2 mu M) and 1-(4-tert-butylbenzyl)-tetrahydropyrimidine-2(1H)-thione 3f (> 100% inhibition at 10 mu M, IC50 = 0.76 mu M) exhibited potent inhibitory effect against alpha-MSH-induced melanin production. Compounds 3 inhibit the biosynthesis of tyrosinase without affecting its catalytic activity in melanogenesis. (C) 2010 Elsevier Ltd. All rights reserved.